PMID- 25881701 OWN - NLM STAT- MEDLINE DCOM- 20150618 LR - 20230711 IS - 0253-9772 (Print) IS - 0253-9772 (Linking) VI - 37 IP - 4 DP - 2015 Apr TI - [IGHMBP2 overexpression promotes cell migration and invasion in esophageal squamous carcinoma]. PG - 360-366 LID - 10.16288/j.yczz.14-371 [doi] AB - Immunoglobulin mu binding protein 2 (IGHMBP2) is located in 11q13.2, which is frequently amplified in esophageal squamous cell carcinoma (ESCC). IGHMBP2 encodes a helicase involved in DNA replication and repair. IGHMBP2 protein also regulates gene transcription. The present study aims to explore the amplification of IGHMBP2 and its potential role in ESCC. A further analysis of our previously reported array-CGH data showed that IGHMBP2 was amplified in 28.9% of primary ESCC tumors. Fluorescence in situ hybridization (FISH) and Western blot showed that IGHMBP2 was amplified and overexpressed in KYSE30, KYSE180, KYSE510 and KYSE150 esophageal cancer cell lines. Transwell assays demonstrated that knockdown of IGHMBP2 in KYSE30 and KYSE150 inhibited cell invasion and migration, and increased the expression levels of E-cadherin. When rescue plasmids expressing IGHMBP2 were introduced, the abilities of cell invasion and migration were restored. These data suggest that IGHMBP2 overexpression may promote invasion and migration of ESCC cells through down-regulation of E-cadherin. FAU - Wang, Chun-Li AU - Wang CL AD - Department of Histology and Embryology, Anhui Medical University, Hefei 230032, China. FAU - Hao, Jia-Jie AU - Hao JJ AD - State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, China. FAU - Wu, Li-Fei AU - Wu LF AD - Department of Gastroenterology, Anqing Municipal Hospital of Anhui Medical University, Anqing 246000, China. FAU - Pan, Bei-Qing AU - Pan BQ AD - State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, China. FAU - Xu, Xin AU - Xu X AD - State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, China. FAU - Cai, Yan AU - Cai Y AD - State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, China. FAU - Wang, Ming-Rong AU - Wang MR AD - State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, China. FAU - Jia, Xue-Mei AU - Jia XM AD - Department of Histology and Embryology, Anhui Medical University, Hefei 230032, China. LA - chi PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Yi Chuan JT - Yi chuan = Hereditas JID - 9436478 RN - 0 (Cadherins) RN - 0 (DNA-Binding Proteins) RN - 0 (IGHMBP2 protein, human) RN - 0 (Transcription Factors) SB - IM MH - Cadherins/genetics/metabolism MH - Carcinoma, Squamous Cell/*genetics/metabolism/pathology/physiopathology MH - Cell Line, Tumor MH - *Cell Movement MH - DNA-Binding Proteins/*genetics/metabolism MH - Esophageal Neoplasms/*genetics/metabolism/pathology/physiopathology MH - Esophageal Squamous Cell Carcinoma MH - Humans MH - Neoplasm Invasiveness MH - Signal Transduction MH - Transcription Factors/*genetics/metabolism EDAT- 2015/04/18 06:00 MHDA- 2015/06/19 06:00 CRDT- 2015/04/18 06:00 PHST- 2015/04/18 06:00 [entrez] PHST- 2015/04/18 06:00 [pubmed] PHST- 2015/06/19 06:00 [medline] AID - 2015-4-360 [pii] AID - 10.16288/j.yczz.14-371 [doi] PST - ppublish SO - Yi Chuan. 2015 Apr;37(4):360-366. doi: 10.16288/j.yczz.14-371.